Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3

被引:76
|
作者
Huang, YH
Galijatovic, A
Nguyen, N
Geske, D
Beaton, D
Green, J
Green, M
Peters, WH
Tukey, RH [1 ]
机构
[1] Univ Calif San Diego, Ctr Canc, Dept Chem & Biochem & Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA
[2] Univ Nijmegen St Radboud Hosp, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands
来源
PHARMACOGENETICS | 2002年 / 12卷 / 04期
关键词
polymorphism; glucuronidation; drug metabolism; pharmacogenomics;
D O I
10.1097/00008571-200206000-00004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
UDP-glucuronosyltransferase (UGT) 1A8 is part of the UGT1 locus and is expressed exclusively in extrahepatic tissues. Analysis of UGT1A8 exon 1 sequence has identified four genotypes from a population of 69 individuals. While there are four alleles, one of the single base pair changes leads to a silent mutation at T-255, while the other mutations lead to amino acid substitutions at positions 173 and 277, creating three allelic variants. UGTlA8*1 (A(173)C(277)), UGTlA8*1a (T-255 A>G), UGT1A8*2 (G(173)C(277)) and UGT1A8*3 (A(173)Y(277)). The allelic frequencies of UGT1A8*1, UGT1A8* 1a, UGT1A8*2 and UGT1A8*3 are 0.551, 0.282, 0.145 and 0.022, respectively. To examine the properties of the UGT1A8 proteins, UGT1A8*1 and UGT1A8*2 were cloned from a human colon cDNA library and UGT1A8*3 generated by mutagenesis using UGT1A8*1 as template. The cDNAs were expressed in HK293 cells to examine catalytic function as well as abundance as observed by analysis of UGT1A8-GFP (green fluorescent protein) expression. The single amino acid change that identifies UGT1A8* 1 (A(173)) and UGT1A8*2 (G(173)) has little impact on function, while the UGT1A8*3 (Y-277) is a conserved amino acid alteration represented by a dramatic reduction in catalytic activity. Protein abundance, as determined by Western blot analysis following transient transfection, is not altered. In addition, functional UGT1A8-GFP variants displayed staining in the cytoplasmic region, indicating that each protein is expressed in similar cellular compartments. Together, these data suggest that the null UGT1A8*3 results from structural changes and not a lack of protein expression. Allelic variation leading to singular codon changes could potentially alter drug metabolism in extrahepatic tissues.
引用
收藏
页码:287 / 297
页数:11
相关论文
共 50 条
  • [21] Potential influence of UGT1A8 genotype on osteoporosis and breast cancer treatment outcome
    Lockwood, Katie
    PHARMACOGENOMICS, 2013, 14 (09) : 1006 - 1006
  • [22] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [23] Low activty UGT1A8 genetic variant is associated with higher mycophenolate exposure.
    Jacobson, Pamala A.
    Kennedy, Melissa
    Oetting, William
    Basu, Saonli
    Sager, Julie
    Kasiske, Bert
    Matas, Arthur
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 184 - 185
  • [24] Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1α and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid
    Vu, Don
    Tellez-Corrales, Eglis
    Yang, Jaewook
    Qazi, Yasir
    Shah, Tariq
    Naraghi, Robert
    Hutchinson, Ian V.
    Min, David I.
    TRANSPLANT IMMUNOLOGY, 2013, 29 (1-4) : 155 - 161
  • [25] Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
    Hideaki Kagaya
    Kazuyuki Inoue
    Masatomo Miura
    Shigeru Satoh
    Mitsuru Saito
    Hitoshi Tada
    Tomonori Habuchi
    Toshio Suzuki
    European Journal of Clinical Pharmacology, 2007, 63 : 279 - 288
  • [26] Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone
    Thibaudeau, J
    Lépine, J
    Tojcic, J
    Duguay, Y
    Pelletier, G
    Plante, M
    Brisson, J
    Têtu, B
    Jacob, S
    Perusse, L
    Bélanger, A
    Guillemette, C
    CANCER RESEARCH, 2006, 66 (01) : 125 - 133
  • [27] Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
    Kagaya, Hideaki
    Inoue, Kazuyuki
    Miura, Masatomo
    Satoh, Shigeru
    Saito, Mitsuru
    Tada, Hitoshi
    Habuchi, Tomonori
    Suzuki, Toshio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 279 - 288
  • [28] Genetic polymorphisms of UGT1A8, UGT1A9, UGT2B7 and ABCC2 in Chinese renal transplant recipients and a comparison with other ethnic populations
    Deng, Xiao-ying
    Wang, Chang-xi
    Wang, Xue-ding
    Bi, Hui-chang
    Chen, Xiao
    Li, Jia-li
    Huang, Min
    PHARMAZIE, 2013, 68 (04): : 240 - 244
  • [29] The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
    Feng Zhao
    Xi Wang
    Yan Wang
    Jingbo Zhang
    Ran Lai
    Bei Zhang
    Xueyan Zhou
    Hormones, 2020, 19 : 403 - 412
  • [30] Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid
    Bernard, Olivier
    Tojcic, Jelena
    Journault, Kim
    Perusse, Louis
    Guillemette, Chantal
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) : 1539 - 1545